Total Payments
$2,641
2024 Payments
$580.06
Companies
19
Transactions
64
Medicare Patients
219
Medicare Billing
$30,439
Payment Breakdown by Category
Food & Beverage$2,422 (91.7%)
Education$218.95 (8.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,422 | 61 | 91.7% |
| Education | $218.95 | 3 | 8.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,049 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $391.93 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $234.19 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $137.35 | 2 | $0 (2024) |
| Ardelyx, Inc. | $130.20 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $119.70 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $110.17 | 6 | $0 (2024) |
| ERBE USA Inc | $90.00 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $76.68 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $63.88 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $580.06 | 9 | ABBVIE INC. ($248.44) |
| 2023 | $1,049 | 20 | ABBVIE INC. ($277.79) |
| 2022 | $788.82 | 27 | ABBVIE INC. ($357.49) |
| 2021 | $209.31 | 7 | AbbVie Inc. ($165.45) |
| 2019 | $13.48 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.48) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $50.95 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.45 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: HCV | ||||||
| 04/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.25 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/28/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $119.89 | General |
| Category: Neuroscience | ||||||
| 11/15/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: CRITICAL CARE | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Gastroenterology | ||||||
| 10/17/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $121.60 | General |
| 09/26/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $130.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/29/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | ERBE USA Inc | Erbe VIO3 (Device) | Food and Beverage | Cash or cash equivalent | $90.00 | General |
| Category: Gastroenterology | ||||||
| 07/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Gastroenterology | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Gastroenterology | ||||||
| 04/25/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 04/20/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2023 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Devices | ||||||
| 03/29/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/23/2023 | Amgen Inc. | AMJEVITA (Biological), AVSOLA | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 186 | 289 | $63,810 | $26,669 |
| 2022 | 2 | 33 | 54 | $10,550 | $3,770 |
Total Patients
219
Total Services
343
Medicare Billing
$30,439
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 142 | $31,950 | $13,754 | 43.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 84 | $14,700 | $5,326 | 36.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $9,760 | $4,500 | 46.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $4,250 | $1,579 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,150 | $1,510 | 47.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 22 | $4,950 | $1,900 | 38.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 32 | $5,600 | $1,870 | 33.4% |
About Dr. Pujyitha Mandiga, MD
Dr. Pujyitha Mandiga, MD is a Internal Medicine healthcare provider based in Parker, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1740771401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pujyitha Mandiga, MD has received a total of $2,641 in payments from pharmaceutical and medical device companies, with $580.06 received in 2024. These payments were reported across 64 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,422).
As a Medicare-enrolled provider, Mandiga has provided services to 219 Medicare beneficiaries, totaling 343 services with total Medicare billing of $30,439. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Parker, CO
- Active Since 05/29/2018
- Last Updated 06/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740771401
Products in Payments
- MAVYRET (Drug) $362.61
- STELARA (Biological) $300.41
- SKYRIZI (Biological) $264.03
- ZEPOSIA (Drug) $234.19
- RINVOQ (Biological) $158.58
- CREON (Drug) $142.35
- IBSRELA (Drug) $130.20
- TERLIVAZ (Drug) $119.70
- ENTYVIO (Biological) $110.17
- TREMFYA (Drug) $109.36
- Epclusa (Drug) $107.10
- Erbe VIO3 (Device) $90.00
- XIFAXAN (Drug) $76.68
- DIFICID (Drug) $63.88
- Sucraid (Drug) $63.65
- DUPIXENT (Biological) $46.53
- SUTAB (Drug) $28.81
- AMJEVITA (Biological) $20.07
- ZENPEP (Drug) $17.09
- QSYMIA (Drug) $15.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parker
Kathryn Polovitz, M.d, M.D
Internal Medicine — Payments: $493,379
Internal Medicine $493,379
Saad Syed Hussain, M.d, M.D
Internal Medicine — Payments: $11,588
Internal Medicine $11,588
Mrs. Beatriz Linn, M.d, M.D
Internal Medicine — Payments: $9,723
Internal Medicine $9,723
Eddie Lipan, Md, MD
Internal Medicine — Payments: $7,263
Internal Medicine $7,263
Mrs. Aldona Staar-Kumosa, Md, MD
Internal Medicine — Payments: $6,799
Internal Medicine $6,799
Rajeev Kandukuri, Md, MD
Internal Medicine — Payments: $5,843
Internal Medicine $5,843